Donald Trump has nominated vaccine skeptic and former Democrat Robert F Kennedy Jr as head of the US Department of Health and Human Services, sparking concern among public health experts and pharmaceutical groups. Kennedy, who has criticized Covid-19 vaccines and the pharmaceutical industry, would oversee agencies such as the FDA and CDC with a focus on transparency and ending chronic disease. Trump’s controversial cabinet nominations, including loyalists Matt Gaetz and Tulsi Gabbard, have raised questions about Senate approval, as industry groups cautiously welcome Kennedy’s appointment.
Full Article
2 Brilliant LNG Stocks to Buy Now and Hold for the Long Term
Global demand for liquefied natural gas (LNG) is projected to increase by 60% by 2040, driven by economic growth in Asia and advancements in AI. Companies like Kinder Morgan (NYSE: KMI) and ConocoPhillips (NYSE: COP) are well-positioned to benefit from this surge, making them strong investment options for the long term. Want More Context? 🔎
Read more